There's a pretty good chance Goldman has sold when-traded OTC contracts on a lot of these hyped up private companies, in effect making themselves short the stoc

There's a pretty good chance Goldman has sold when-traded OTC contracts on a lot of these hyped up private companies, in effect making themselves short the stock. Hence the WSJ article. Actually when you think of it this way and realize they have probably fleeced a lot of dumb third world money, the whole Theranos board setup makes more sense.